432 related articles for article (PubMed ID: 18063832)
21. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
22. Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: a multicenter confirmatory study.
Castellanos M; Sobrino T; Millán M; García M; Arenillas J; Nombela F; Brea D; Perez de la Ossa N; Serena J; Vivancos J; Castillo J; Dávalos A
Stroke; 2007 Jun; 38(6):1855-9. PubMed ID: 17478737
[TBL] [Abstract][Full Text] [Related]
23. Expediting MRI-based proof-of-concept stroke trials using an earlier imaging end point.
Ebinger M; Christensen S; De Silva DA; Parsons MW; Levi CR; Butcher KS; Bladin CF; Barber PA; Donnan GA; Davis SM;
Stroke; 2009 Apr; 40(4):1353-8. PubMed ID: 19246703
[TBL] [Abstract][Full Text] [Related]
24. Reperfusion after 4.5 hours reduces infarct growth and improves clinical outcomes.
Picanço MR; Christensen S; Campbell BC; Churilov L; Parsons MW; Desmond PM; Barber PA; Levi CR; Bladin CF; Donnan GA; Davis SM;
Int J Stroke; 2014 Apr; 9(3):266-9. PubMed ID: 24256139
[TBL] [Abstract][Full Text] [Related]
25. The rtPA increases MMP-9 activity in serum during ischaemic stroke.
Gołąb P; Boguszewska-Czubara A; Kiełbus M; Kurzepa J
Neurol Neurochir Pol; 2014; 48(5):309-14. PubMed ID: 25440008
[TBL] [Abstract][Full Text] [Related]
26. Magnetic Resonance Imaging-DRAGON score: 3-month outcome prediction after intravenous thrombolysis for anterior circulation stroke.
Turc G; Apoil M; Naggara O; Calvet D; Lamy C; Tataru AM; Méder JF; Mas JL; Baron JC; Oppenheim C; Touzé E
Stroke; 2013 May; 44(5):1323-8. PubMed ID: 23482603
[TBL] [Abstract][Full Text] [Related]
27. Ischemic stunning of the brain: early recanalization without immediate clinical improvement in acute ischemic stroke.
Alexandrov AV; Hall CE; Labiche LA; Wojner AW; Grotta JC
Stroke; 2004 Feb; 35(2):449-52. PubMed ID: 14726543
[TBL] [Abstract][Full Text] [Related]
28. Large ischemic lesions on diffusion-weighted imaging done before intravenous tissue plasminogen activator thrombolysis predicts a poor outcome in patients with acute stroke.
Kimura K; Iguchi Y; Shibazaki K; Terasawa Y; Inoue T; Uemura J; Aoki J
Stroke; 2008 Aug; 39(8):2388-91. PubMed ID: 18535272
[TBL] [Abstract][Full Text] [Related]
29. White matter hyperintensity volume correlates with matrix metalloproteinase-2 in acute ischemic stroke.
Corbin ZA; Rost NS; Lorenzano S; Kernan WN; Parides MK; Blumberg JB; Milbury PE; Arai K; Hartdegen SN; Lo EH; Feske SK; Furie KL
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1300-6. PubMed ID: 24439130
[TBL] [Abstract][Full Text] [Related]
30. [ASPECTS-DWI, arterial occlusion sites and subtype of acute ischemic stroke have a relation with outcome following intravenous rt-PA therapy].
Idei M; Sasaki T; Tanabe T; Muraoka K; Terada K; Meguro T; Hirotsune N; Nishino S
No Shinkei Geka; 2012 Jul; 40(7):585-91. PubMed ID: 22728535
[TBL] [Abstract][Full Text] [Related]
31. A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke.
Rosell A; Alvarez-Sabín J; Arenillas JF; Rovira A; Delgado P; Fernández-Cadenas I; Penalba A; Molina CA; Montaner J
Stroke; 2005 Jul; 36(7):1415-20. PubMed ID: 15947272
[TBL] [Abstract][Full Text] [Related]
32. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
33. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study.
Labiche LA; Al-Senani F; Wojner AW; Grotta JC; Malkoff M; Alexandrov AV
Stroke; 2003 Mar; 34(3):695-8. PubMed ID: 12624293
[TBL] [Abstract][Full Text] [Related]
34. High serum levels of endothelin-1 predict severe cerebral edema in patients with acute ischemic stroke treated with t-PA.
Moldes O; Sobrino T; Millán M; Castellanos M; Pérez de la Ossa N; Leira R; Serena J; Vivancos J; Dávalos A; Castillo J
Stroke; 2008 Jul; 39(7):2006-10. PubMed ID: 18436890
[TBL] [Abstract][Full Text] [Related]
35. Increased Plasma Matrix Metalloproteinase-9 Levels Contribute to Intracerebral Hemorrhage during Thrombolysis after Concomitant Stroke and Influenza Infection.
Muhammad S; Planz O; Schwaninger M
Cerebrovasc Dis Extra; 2016; 6(2):50-9. PubMed ID: 27560521
[TBL] [Abstract][Full Text] [Related]
36. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia.
Tsuji K; Aoki T; Tejima E; Arai K; Lee SR; Atochin DN; Huang PL; Wang X; Montaner J; Lo EH
Stroke; 2005 Sep; 36(9):1954-9. PubMed ID: 16051896
[TBL] [Abstract][Full Text] [Related]
37. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke.
Switzer JA; Hess DC; Ergul A; Waller JL; Machado LS; Portik-Dobos V; Pettigrew LC; Clark WM; Fagan SC
Stroke; 2011 Sep; 42(9):2633-5. PubMed ID: 21737808
[TBL] [Abstract][Full Text] [Related]
39. A higher body temperature is associated with haemorrhagic transformation in patients with acute stroke untreated with recombinant tissue-type plasminogen activator (rtPA).
Leira R; Sobrino T; Blanco M; Campos F; Rodríguez-Yáñez M; Castellanos M; Moldes O; Millán M; Dávalos A; Castillo J
Clin Sci (Lond); 2012 Feb; 122(3):113-9. PubMed ID: 21861843
[TBL] [Abstract][Full Text] [Related]
40. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators.
Warach S; Pettigrew LC; Dashe JF; Pullicino P; Lefkowitz DM; Sabounjian L; Harnett K; Schwiderski U; Gammans R
Ann Neurol; 2000 Nov; 48(5):713-22. PubMed ID: 11079534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
